TY - JOUR
T1 - Germline predisposition and copy number alteration in pre-stage lung adenocarcinomas presenting as ground-glass nodules
AU - Ren, Yijiu
AU - Huang, Shujun
AU - Dai, Chenyang
AU - Xie, Dong
AU - Zheng, Larry
AU - Xie, Huikang
AU - Zheng, Hui
AU - She, Yunlang
AU - Zhou, Fangyu
AU - Wang, Yue
AU - Li, Pengpeng
AU - Fei, Ke
AU - Jiang, Gening
AU - Zhang, Yang
AU - Su, Bo
AU - Alejandro Sweet-Cordero, E.
AU - Tran, Nhan Le
AU - Yang, Yanan
AU - Patel, Jai N.
AU - Rolfo, Christian
AU - Rocco, Gaetano
AU - Cardona, Andrés Felipe
AU - Tuzi, Alessandro
AU - Suter, Matteo B.
AU - Yang, Ping
AU - Xu, Wayne
AU - Chen, Chang
N1 - Funding Information:
This project is funded by the Shanghai Hospital Development Center (SHDC12015116), the Shanghai Lingjun Program (2015057), and the Shanghai Pujiang Program (15PJD034). This study is also partially supported by the CancerCare Manitoba Foundation (CCMF) grant (WX).
Publisher Copyright:
© 2007-2019 Frontiers Media S.A. All Rights Reserved.
PY - 2019
Y1 - 2019
N2 - Objective: Synchronous multiple ground-glass nodules (SM-GGNs) are a distinct entity of lung cancer which has been emerging increasingly in recent years in China. The oncogenesis molecular mechanisms of SM-GGNs remain elusive. Methods: We investigated single nucleotide variations (SNV), insertions and deletions (INDEL), somatic copy number variations (CNV), and germline mutations of 69 SM-GGN samples collected from 31 patients, using target sequencing (TRS) and whole exome sequencing (WES). Results: In the entire cohort, many known driver mutations were found, including EGFR (21.7%), BRAF (14.5%), and KRAS (6%). However, only one out of the 31 patients had the same somatic missense or truncated events within SM-GGNs, indicating the independent origins for almost all of these SM-GGNs. Many germline mutations with a low frequency in the Chinese population, and genes harboring both germline and somatic variations, were discovered in these pre-stage GGNs. These GGNs also bore large segments of copy number gains and/or losses. The CNV segment number tended to be positively correlated with the germline mutations (r = 0.57). The CNV sizes were correlated with the somatic mutations (r = 0.55). A moderate correlation (r = 0.54) was also shown between the somatic and germline mutations. Conclusion: Our data suggests that the precancerous unstable CNVs with potentially predisposing genetic backgrounds may foster the onset of driver mutations and the development of independent SM-GGNs during the local stimulation of mutagens.
AB - Objective: Synchronous multiple ground-glass nodules (SM-GGNs) are a distinct entity of lung cancer which has been emerging increasingly in recent years in China. The oncogenesis molecular mechanisms of SM-GGNs remain elusive. Methods: We investigated single nucleotide variations (SNV), insertions and deletions (INDEL), somatic copy number variations (CNV), and germline mutations of 69 SM-GGN samples collected from 31 patients, using target sequencing (TRS) and whole exome sequencing (WES). Results: In the entire cohort, many known driver mutations were found, including EGFR (21.7%), BRAF (14.5%), and KRAS (6%). However, only one out of the 31 patients had the same somatic missense or truncated events within SM-GGNs, indicating the independent origins for almost all of these SM-GGNs. Many germline mutations with a low frequency in the Chinese population, and genes harboring both germline and somatic variations, were discovered in these pre-stage GGNs. These GGNs also bore large segments of copy number gains and/or losses. The CNV segment number tended to be positively correlated with the germline mutations (r = 0.57). The CNV sizes were correlated with the somatic mutations (r = 0.55). A moderate correlation (r = 0.54) was also shown between the somatic and germline mutations. Conclusion: Our data suggests that the precancerous unstable CNVs with potentially predisposing genetic backgrounds may foster the onset of driver mutations and the development of independent SM-GGNs during the local stimulation of mutagens.
UR - http://www.scopus.com/inward/record.url?scp=85066735130&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066735130&partnerID=8YFLogxK
U2 - 10.3389/fonc.2019.00288
DO - 10.3389/fonc.2019.00288
M3 - Article
AN - SCOPUS:85066735130
SN - 2234-943X
VL - 9
JO - Frontiers in Oncology
JF - Frontiers in Oncology
IS - MAR
M1 - 288
ER -